Oct 20, 2021 ACIP Meeting – Influenza Vaccines

Share it with your friends Like

Thanks! Share it with your friends!

Close

Introduction; Phase II safety and immunogenicity study of the coadministration of
Fluzone® High-Dose Quadrivalent Influenza Vaccine and a third dose of Change in Age Indication for Flucelvax Quadrivalent

This video can also be viewed at
https://www.cdc.gov/vaccines/videos/low-res/ACIPOct2021/ACIP-3_InfluenzaVaccines_10-20-2021_LowRes.mp4

Comments

Write a comment